JPRN-UMIN000011370已完成2 期
Phase II study of alternate-day treatment with S-1 as adjuvant chemotherapy for patients with lung cancer. - Phase II study of alternate-day treatment with S-1 as adjuvant chemotherapy for patients with lung cancer.
Chiba University Graduate School of Medicine0 个研究点目标入组 25 人开始时间: 2013年8月5日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) patients who cannot take S-1 1.with severe allergic history against the ingredients of S-1. 2. with sever bone marrow suppression, renal or liver dysfunction 3. patients who need other fluorouracil 4. patients who need flucitosine. 2) with severe allergic history against medicines 3) with history of myocardial infarction in 6 months. 4)with other severe diseases (cardiac failure,mental disorder, infection or other severe complications) 5) with uncontrolled DM 6) with watery diarrhea 7) with double cancer and or multiple cancer 8)doctors' stop not to register to the study
研究者
相似试验
已完成
2 期
A phase II study of S-1 (14days-administrarion followed by 7days-rest ) for Metastatic Breast CancerBreast CancerJPRN-UMIN000014096Tokyo Women's Medical University25
已完成
2 期
Phase II study of alternate-day administrations of S-1 as 2nd-line treatment in patients with metastatic and locally advanced pancreatic cancerMetastatic or locally advanced pancreatic cancerJPRN-UMIN000003454Pancreatic Cancer Treatment Research Group45
已完成
2 期
Phase II Study of Alternate-day Administration of S-1 plus Carboplatin in Elderly Patients with Advanced Non-small Cell Lung Canceron-small Cell Lung CancerJPRN-UMIN000012098Tokushukai Group Oncology Project45
已完成
2 期
Phase II Study of Alternate-day Administration of S-1 plus Carboplatin in Elderly Patients with Previously Treated Non-small Cell Lung CancerJPRN-UMIN000010989Tokushukai Group Oncology Project32
已完成
2 期
Phase II study of alternate-day administrations of S-1 as 1st-line treatment in patients with metastatic and locally advanced pancreatic cancerMetastatic or locally advanced pancreatic cancerJPRN-UMIN000003453Pancreatic Cancer Treatment Research Group45